The Food and Drug Administration perspective: Use of an investigational drug in a medical emergency

Anesthesia and Analgesia

Volumn 104, Issue 3, 2007, Pages 479-480

  Schultheis, Lex W ^a   Rappaport, Bob A ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUGAMMADEX;

ANESTHESIOLOGY; CLINICAL STUDY; DRUG APPROVAL; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; EDITORIAL; EMERGENCY TREATMENT; FOOD AND DRUG ADMINISTRATION; HUMAN; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; PRIORITY JOURNAL;

CLINICAL TRIALS; DRUG APPROVAL; DRUG EVALUATION; DRUG INDUSTRY; DRUG THERAPY; DRUGS, INVESTIGATIONAL; EMERGENCIES; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33847182764     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000257291.34935.ad     Document Type: Editorial

References (1)

1. Lenz A, Hill G, White PF. The emergency use of sugammadex after failure of standard reversal drugs. Anesth Analg 2007;104:585-6.